Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Ciofini

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Cancers|December 30, 2020
Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of <i>FLT3</i>-ITD in <i>NPM1</i> Mutated AML, Irrespectively of <i>FLT3</i>-ITD Allelic BurdenPaola Minetto, Anna Candoni, Fabio Guolo, et al.
Leukemia|October 24, 2024
Apoliprotein E-mediated ferroptosis controls cellular proliferation in chronic lymphocytic leukemiaFederica Nardi, Rosita Del Prete, Roberta Drago, et al.
Cytometry. Part B, Clinical Cytometry|February 5, 2019
Flow Cytometry Assessment of CD26<sup>+</sup> Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid LeukemiaDonatella Raspadori, Paola Pacelli, Anna Sicuranza, et al.
British Journal of Haematology|March 26, 2026
MRD-negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥VGPR/MRD-positive after first-line therapy: Final analysis of the open-label, single-arm multicentric phase 2 trial DART4MMAlessandro Gozzetti, Paola Pacelli, Federico Caroni, et al.
American Journal of Hematology|April 7, 2022
Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factorsAlessandro Gozzetti, Andrea Guarnieri, Elena Zamagni, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Cancers|December 30, 2020
Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of <i>FLT3</i>-ITD in <i>NPM1</i> Mutated AML, Irrespectively of <i>FLT3</i>-ITD Allelic BurdenPaola Minetto, Anna Candoni, Fabio Guolo, et al.
Leukemia|October 24, 2024
Apoliprotein E-mediated ferroptosis controls cellular proliferation in chronic lymphocytic leukemiaFederica Nardi, Rosita Del Prete, Roberta Drago, et al.
Cytometry. Part B, Clinical Cytometry|February 5, 2019
Flow Cytometry Assessment of CD26<sup>+</sup> Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid LeukemiaDonatella Raspadori, Paola Pacelli, Anna Sicuranza, et al.
British Journal of Haematology|March 26, 2026
MRD-negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥VGPR/MRD-positive after first-line therapy: Final analysis of the open-label, single-arm multicentric phase 2 trial DART4MMAlessandro Gozzetti, Paola Pacelli, Federico Caroni, et al.
American Journal of Hematology|April 7, 2022
Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factorsAlessandro Gozzetti, Andrea Guarnieri, Elena Zamagni, et al.
Pageof 3